Justin Lucas

Justin Lucas has worked in the field of translational research since 2010. Their career began at Pfizer, where they worked as a Scientist from 2010 to 2018. Justin then moved to Bristol Myers Squibb, where they held the role of Principle Clinical Biomarker Scientist from 2019 to 2020, and Senior Research Investigator from 2018 to 2019. In 2020, they joined The Janssen Pharmaceutical Companies of Johnson & Johnson as Principal Scientist: Oncology Translational Research Lead. Most recently, they were appointed Head of Translational Research at Adlai Nortye USA Inc. in 2022.

Justin Lucas completed a Bachelor of Science (BS) in Biology/Biological Sciences, General from Lafayette College in 2010. Justin then went on to obtain a Master of Science (MS) in Pathology/Experimental Pathology from New York Medical College in 2013. Finally, they earned a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from New York Medical College in 2018.